PYGL

glycogen phosphorylase L, the group of Glycogen phosphorylases

Basic information

Region (hg38): 14:50857891-50944483

Links

ENSG00000100504NCBI:5836OMIM:613741HGNC:9725Uniprot:P06737AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • glycogen storage disease VI (Definitive), mode of inheritance: AR
  • glycogen storage disease VI (Strong), mode of inheritance: AR
  • glycogen storage disease VI (Strong), mode of inheritance: AR
  • glycogen storage disease VI (Strong), mode of inheritance: AR
  • glycogen storage disease VI (Supportive), mode of inheritance: AR
  • glycogen storage disease VI (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Glycogen storage disease VIARBiochemicalThe condition can include manifestations suc has hypoglycemia, ketosis, and growth retardation, and recommendations for care include laboratory-based monitoring (eg, including liver function tests, glucose, and ketones), radiological monitoring (abdominal imaging), and nutritional recommendations and avoidance of certain medications in order to help improve metabolic to control and prevent the primary complications; Specific care during pregnancy has been recommendedBiochemical13646331; 5904467; 9529348; 9536091; 17705025; 20301788; 21646031; 25266922; 30659246

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PYGL gene.

  • Glycogen_storage_disease,_type_VI (259 variants)
  • Inborn_genetic_diseases (74 variants)
  • not_provided (72 variants)
  • not_specified (23 variants)
  • PYGL-related_disorder (21 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PYGL gene is commonly pathogenic or not. These statistics are base on transcript: NM_000002863.5. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
3
clinvar
57
clinvar
1
clinvar
62
missense
6
clinvar
14
clinvar
154
clinvar
13
clinvar
2
clinvar
189
nonsense
13
clinvar
7
clinvar
1
clinvar
21
start loss
1
1
frameshift
12
clinvar
9
clinvar
1
clinvar
22
splice donor/acceptor (+/-2bp)
11
clinvar
6
clinvar
1
clinvar
18
Total 42 37 161 70 3

Highest pathogenic variant AF is 0.000145594

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PYGLprotein_codingprotein_codingENST00000216392 2086846
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.71e-170.4924175726796571951257480.424
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.2034784661.030.00002545610
Missense in Polyphen246239.071.0292934
Synonymous0.2971771820.9720.00001031601
Loss of Function1.743345.70.7220.00000259525

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American1.311.31
Ashkenazi Jewish0.3380.335
East Asian0.6100.607
Finnish0.3600.361
European (Non-Finnish)0.3430.342
Middle Eastern0.6100.607
South Asian0.4460.442
Other0.4080.407

dbNSFP

Source: dbNSFP

Function
FUNCTION: Phosphorylase is an important allosteric enzyme in carbohydrate metabolism. Enzymes from different sources differ in their regulatory mechanisms and in their natural substrates. However, all known phosphorylases share catalytic and structural properties.;
Disease
DISEASE: Glycogen storage disease 6 (GSD6) [MIM:232700]: A metabolic disorder characterized by mild to moderate hypoglycemia, mild ketosis, growth retardation, and prominent hepatomegaly. Heart and skeletal muscle are not affected. {ECO:0000269|PubMed:9529348}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Insulin resistance - Homo sapiens (human);Starch and sucrose metabolism - Homo sapiens (human);Glucagon signaling pathway - Homo sapiens (human);Necroptosis - Homo sapiens (human);Insulin signaling pathway - Homo sapiens (human);Glycogen synthetase deficiency;Glycogenosis, Type III. Cori disease, Debrancher glycogenosis;Mucopolysaccharidosis VI. Sly syndrome;Sucrase-isomaltase deficiency;Glycogenosis, Type IV. Amylopectinosis, Anderson disease;Glycogenosis, Type VI. Hers disease;Starch and Sucrose Metabolism;TNF alpha Signaling Pathway;Glycogen Metabolism;Neutrophil degranulation;Metabolism of carbohydrates;glycogenolysis;Innate Immune System;Immune System;Metabolism;Glycogen breakdown (glycogenolysis);Glycogen metabolism (Consensus)

Recessive Scores

pRec
0.423

Intolerance Scores

loftool
0.0522
rvis_EVS
0.21
rvis_percentile_EVS
67.5

Haploinsufficiency Scores

pHI
0.242
hipred
N
hipred_score
0.492
ghis
0.496

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.992

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pygl
Phenotype

Gene ontology

Biological process
glycogen metabolic process;glycogen catabolic process;5-phosphoribose 1-diphosphate biosynthetic process;response to bacterium;glucose homeostasis;neutrophil degranulation;necroptotic process
Cellular component
extracellular region;cytoplasm;cytosol;secretory granule lumen;extracellular exosome;ficolin-1-rich granule lumen
Molecular function
purine nucleobase binding;protein binding;ATP binding;glucose binding;drug binding;glycogen phosphorylase activity;AMP binding;vitamin binding;pyridoxal phosphate binding;bile acid binding;protein homodimerization activity;linear malto-oligosaccharide phosphorylase activity;SHG alpha-glucan phosphorylase activity